GENE ONLINE|News &
Opinion
Blog

2018-05-15|

May 14, 2005: Piggybac as a Genetic Manipulation Tool for Analyzing Vertebrates, Patent Application Submitted to WIPO

by GeneOnline
Share To

The PiggyBac (PB) transposon is a mobile genetic element that can transpose between vectors and chromosomes via a “cut and paste” mechanism, and thus PiggyBac is an important tool related to transgenic technique. One specific technique using Piggybac as a tool for genetic manipulation and analysis in vertebrates was previously granted by the patent offices in the US, Europe, Canada, Japan, and China. On May 14, 2005, the inventors submitted a patent application to the World Intellectual Property Organization (WIPO) for this technique. Using PB transposon to transfer targeted gene fragment from vector into chromosome can effectively transplant targeted gene into the gene of certain organisms. In addition, PiggyBac technology is also equipped with a unique reversible characteristic.

Reference
http://europepmc.org/patents/PAT/CA2608481
https://en.wikipedia.org/wiki/PiggyBac_Transposon_System

Image Source
https://www.systembio.com/products/gene-expression-systems/piggybac-transposon/

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Merck Faces Patent Battle with Halozyme Over Latest Keytruda Injection
2025-03-09
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Bristol Myers Squibb Requests $1.2 Billion Patent Revival From Supreme Court
2022-06-17
LATEST
Lupin Secures US FDA Tentative Approval for Oxcarbazepine ER Tablets Manufactured in Nagpur
2025-06-18
Investor Trust and Market Timing Shape the New IPO Playbook
2025-06-18
Global Pharmaceutical Sector Records $6.96 Billion in May 2025 Deal Activity with Three Major Agreements Driving 59 Percent of M&A Value
2025-06-18
Eli Lilly Acquires SiteOne Therapeutics to Develop Non-Opioid Pain Treatment STC-004
2025-06-18
New Device Promises to Streamline CAR T-Cell Therapy Production for Earlier Cancer Treatment
2025-06-18
Roche Reports Near-Complete Suppression of Disability Progression in RMS Patients Over Two Years with BTK Inhibitor
2025-06-18
Technological Advancements Reduce R&D Costs and Propel Growth of Cell and Gene Therapies in Biopharmaceutical Sector
2025-06-18
EVENT
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top